HUE054691T2 - Eljárás 3,7-bisz(dimetilamino)fenotiazin-5-ílium-jodid elõállítására - Google Patents

Eljárás 3,7-bisz(dimetilamino)fenotiazin-5-ílium-jodid elõállítására

Info

Publication number
HUE054691T2
HUE054691T2 HUE18712446A HUE18712446A HUE054691T2 HU E054691 T2 HUE054691 T2 HU E054691T2 HU E18712446 A HUE18712446 A HU E18712446A HU E18712446 A HUE18712446 A HU E18712446A HU E054691 T2 HUE054691 T2 HU E054691T2
Authority
HU
Hungary
Prior art keywords
phenothiazine
dimethylamino
bis
preparation
ylium iodide
Prior art date
Application number
HUE18712446A
Other languages
English (en)
Inventor
Michel Feraud
Babak Sayah
Stephane Queru
Marina Laurent
Original Assignee
Provepharm Life Solutions
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provepharm Life Solutions filed Critical Provepharm Life Solutions
Publication of HUE054691T2 publication Critical patent/HUE054691T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B21/00—Thiazine dyes
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
    • C09B67/0096—Purification; Precipitation; Filtration
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE18712446A 2017-03-02 2018-02-16 Eljárás 3,7-bisz(dimetilamino)fenotiazin-5-ílium-jodid elõállítására HUE054691T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1751700A FR3063495B1 (fr) 2017-03-02 2017-03-02 Procede de preparation de l’iodure de 3,7-bis(dimethylamino)phenothiazine-5-ylium

Publications (1)

Publication Number Publication Date
HUE054691T2 true HUE054691T2 (hu) 2021-09-28

Family

ID=59031095

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE18712446A HUE054691T2 (hu) 2017-03-02 2018-02-16 Eljárás 3,7-bisz(dimetilamino)fenotiazin-5-ílium-jodid elõállítására

Country Status (17)

Country Link
US (2) US11078169B2 (hu)
EP (1) EP3589622B1 (hu)
JP (3) JP2020509019A (hu)
KR (2) KR102558527B1 (hu)
CN (2) CN116410155A (hu)
AU (1) AU2018228816B2 (hu)
BR (1) BR112019018208A2 (hu)
CA (1) CA3054659A1 (hu)
DK (1) DK3589622T3 (hu)
ES (1) ES2877117T3 (hu)
FR (1) FR3063495B1 (hu)
HU (1) HUE054691T2 (hu)
MX (1) MX2019010266A (hu)
PL (1) PL3589622T3 (hu)
PT (1) PT3589622T (hu)
RU (1) RU2768139C2 (hu)
WO (1) WO2018158520A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3063495B1 (fr) * 2017-03-02 2019-04-05 Provepharm Life Solutions Procede de preparation de l’iodure de 3,7-bis(dimethylamino)phenothiazine-5-ylium
US20230138553A1 (en) * 2020-02-28 2023-05-04 Dishman Carbogen Amcis Ltd. A Process for the Preparation of Methylene Blue

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2373787A (en) 2001-03-08 2002-10-02 Univ Central Lancashire Phenothiazinium derivatives and their use to reduce pathogenic contaminants
CA2379211A1 (fr) 2002-03-28 2003-09-28 Institut De Cardiologie De Montreal Utilisation du bleu de methylene pour renverser la reaction hemodynamique exageree induite par la combinaison d'un derive nitre et du sildenafil ou d'une molecule de meme classe (inhibiteur de la phosphodiesterase)
RU2233274C1 (ru) * 2002-12-25 2004-07-27 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" Способ получения 10-(3-диметиламино-2-метилпропил)-2-метоксифенотиазина
AU2004295148A1 (en) * 2003-11-28 2005-06-16 Photopharmica Limited Developments in biologically active methylene blue derivatives (2)
GB0327672D0 (en) * 2003-11-28 2003-12-31 Photopharmica Ltd Developments in biologically active methylene blue derivatives (phenothiazines)
ES2736160T3 (es) 2004-09-23 2019-12-26 Wista Lab Ltd Procedimientos de síntesis química y purificación de compuestos de diaminofenotiazinio que incluyen cloruro de metiltioninio (CMT)
US8263589B2 (en) * 2006-03-29 2012-09-11 Wista Laboratories Ltd. Inhibitors of protein aggregation
PL2057136T3 (pl) * 2006-07-11 2013-10-31 Wista Lab Ltd Sposoby syntezy i/lub oczyszczania związków diaminofenotiazynowych
FR2903696B1 (fr) 2006-07-12 2011-02-11 Provence Technologies Procede de purification de composes diaminophenothiazium
CA2976776C (en) * 2015-02-17 2023-06-20 Arizona Board Of Regents On Behalf Of Arizona State University Phenothiazine analogues as mitochondrial therapeutic agents
FR3063495B1 (fr) * 2017-03-02 2019-04-05 Provepharm Life Solutions Procede de preparation de l’iodure de 3,7-bis(dimethylamino)phenothiazine-5-ylium

Also Published As

Publication number Publication date
EP3589622A1 (fr) 2020-01-08
US20210323937A1 (en) 2021-10-21
CA3054659A1 (fr) 2018-09-07
KR102558527B1 (ko) 2023-07-21
DK3589622T3 (da) 2021-06-21
JP7482161B2 (ja) 2024-05-13
AU2018228816B2 (en) 2021-09-30
KR20230074848A (ko) 2023-05-31
WO2018158520A1 (fr) 2018-09-07
MX2019010266A (es) 2019-10-14
RU2019126407A3 (hu) 2021-04-27
AU2018228816A1 (en) 2019-09-12
PT3589622T (pt) 2021-06-03
CN110382472B (zh) 2023-05-09
US20200010438A1 (en) 2020-01-09
FR3063495B1 (fr) 2019-04-05
US11078169B2 (en) 2021-08-03
FR3063495A1 (fr) 2018-09-07
EP3589622B1 (fr) 2021-03-31
RU2019126407A (ru) 2021-04-02
US11891367B2 (en) 2024-02-06
JP2020509019A (ja) 2020-03-26
BR112019018208A2 (pt) 2020-06-23
KR20190125366A (ko) 2019-11-06
ES2877117T3 (es) 2021-11-16
PL3589622T3 (pl) 2021-10-18
CN116410155A (zh) 2023-07-11
JP2022068343A (ja) 2022-05-09
RU2768139C2 (ru) 2022-03-23
CN110382472A (zh) 2019-10-25
JP2023011886A (ja) 2023-01-24

Similar Documents

Publication Publication Date Title
SI3355884T1 (sl) Antiestrogenska zdravila tetrahidro-1H-pirido(3,4-b)indola
SG10201601501QA (en) Preparation of 2,2`-biaryls in the presence of molybdenum(v) chloride
GB2540427B (en) Process for the preparation of 2,3,3,3-tetrafluoropropene (1234yf)
IL260303B (en) Process for preparing 3,1,1-trioxo-2,1-benzothiazole-6-carboxamide
PL3386994T3 (pl) 4,6-di-(o-tiofosforano)-inozytolo-1,2,3,5-tetra-o-siarczan dla zakażenia c. difficile
HK1254379A1 (zh) 烯基苯氧基取代的1，1-二苯基乙烯、它們的製備方法和它們的用途
IL268835B (en) A process for the preparation of 2-cyanoimidazole compounds
SG11201803584RA (en) 1,4-dicarbonyl-piperidyl derivatives
HK1254800A1 (zh) 2，3，4，5-四氫吡啶-6-胺衍生物
IL260306B (en) Process for preparing 1,1,3-trioxo-1,2-benzothiazole-6-carboxamide
PL3589622T3 (pl) Sposób przygotowywania jodku 3,7-bis(dimetyloamino)fenotiazyn-5-yliowego
ZA202004349B (en) Fluoralkenyl compounds, process for preparation and use thereof
IL275480A (en) A process for the preparation of pyrimidinyl-4-aminopyrazole compounds
GB2540428B (en) Process for preparing 3,3,3-trifluoropropene
ZA202204747B (en) D-amphetamine compounds, compositions, and processes for making and using the same
EP3548457A4 (en) IMPROVED METHOD FOR PRODUCING 2,3,3,3-TETRAFLUORPROPEN
GB201805255D0 (en) Process for the preparation of 17beta-hydroxy-des-a-androst-9, 10-en-5-one
PL3274339T3 (pl) Sposób wytwarzania chlorowodorków 2- (homo)-piperazyno-1,3-benzotiazyn-4-onu
HUE065487T2 (hu) Eljárás 3,3,3-trifluorprop-1-én elõállítására
EP3877361C0 (en) PROCESS FOR PREPARING ARYLSULFONYLPROPENENITRILE
EP3638220A4 (en) PREPARATION OF (S, S
IL251229A0 (en) Process for preparing 5-bromo-1,2,3-trichlorobenzene
IL274560A (en) A process for the preparation of raltagravir
GB201713146D0 (en) Process for the preparation of glycidol
GB201708375D0 (en) Process for the preparation of glycidol